Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98,685,316
-
Total 13F shares
-
152,616,988
-
Share change
-
+11,672,128
-
Total reported value
-
$4,987,163,440
-
Put/Call ratio
-
170%
-
Price per share
-
$32.68
-
Number of holders
-
201
-
Value change
-
+$334,963,468
-
Number of buys
-
101
-
Number of sells
-
106
Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2021
As of 31 Dec 2021 GoodRx Holdings, Inc. - Common Stock (GDRX) had 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 152,616,988 shares of stock of the company.
Largest 10 holders included Francisco Partners Management, LP, MORGAN STANLEY, Abdiel Capital Advisors, LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Silver Lake Group, L.L.C., TIGER GLOBAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Carmignac Gestion, and Technology Crossover Management X, Ltd..
This table shows 202 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.